SCHEMBL7399582

SCHEMBL7399582

COc1ccc(N2CCN(CCC3OCCc4ccc(Br)cc43)CC2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 11/20 0.74
HTR2A P28223 7/20 0.74
HTR1D P28221 7/20 0.74
DRD4 P21917 7/20 0.74
HTR1A P08908 5/20 0.74
HTR1B P28222 1/20 0.62
ADRA2A P08913 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55
DRD1 P21728 1/20 0.55
ADRA1D P25100 1/20 0.55
ADRA1A P35348 1/20 0.55
ADRA1B P35368 1/20 0.55
DRD3 P35462 1/20 0.55
HTR2B P41595 1/20 0.55
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA4 P22748 1/20 0.51
CA6 P23280 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7403729 0.92 DRD2 (0.74) DRD2HTR2AHTR1DDRD4HTR1A
SCHEMBL8591943 0.92 DRD2 (0.74) DRD2HTR2AHTR1DDRD4HTR1A
SCHEMBL8590932 0.92 DRD2 (0.74) DRD2HTR2AHTR1DDRD4HTR1A
Hydrochloric Acid SCHEMBL7403803 0.91 DRD2 (0.73) DRD2HTR2AHTR1DDRD4HTR1A
SCHEMBL7403843 0.89 DRD2 (0.76) DRD2HTR2AHTR1DDRD4HTR1A
Hydrochloric Acid SCHEMBL7396772 0.88 DRD2 (0.74) DRD2HTR2AHTR1DDRD4HTR1A
SCHEMBL8642441 0.86 DRD2 (0.77) DRD2HTR2AHTR1DDRD4HTR1A
SCHEMBL5698958 0.85 DRD2 (1.00) DRD2HTR2AHTR1DDRD4HTR1A
SCHEMBL7402753 0.85 HTR1D (0.86) DRD2HTR2AHTR1DDRD4HTR1A
Hydrochloric Acid SCHEMBL7400497 0.85 DRD2 (0.98) DRD2HTR2AHTR1DDRD4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP claimed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP claimed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO claimed
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
EP-0737189-B1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS UPJOHN CO (US) 1999-07-28 EP disclosed
US-5877317-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 1999-03-02 US disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed